Monifa Brooks, MD
Physical Medicine & Rehabilitation · West Orange, NJNPI 1386633105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 24.0% of the total. Reporting peaked in 2019 at $343 and has fallen 56.4% since, to $149 in 2025.
Across 64 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$247
- Merz Pharmaceuticals, LLC$138
- Azurity Pharmaceuticals, Inc.$81
- Merz North America, Inc.$57
- Avanir Pharmaceuticals, Inc.$56
- Argenx US, Inc.$54
- plus $396 from 18 others
What the payments were for
- Food & beverage$1,029100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 16 | $247 |
| Merz Pharmaceuticals, LLC | 7 | $138 |
| Azurity Pharmaceuticals, Inc. | 5 | $81 |
| Merz North America, Inc. | 3 | $57 |
| Avanir Pharmaceuticals, Inc. | 4 | $56 |
| Argenx US, Inc. | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 3 | $40 |
| Coloplast | 2 | $38 |
| Pfizer | 2 | $30 |
| Vertex | 2 | $29 |
| Bioventus LLC | 1 | $29 |
| AstraZeneca | 2 | $27 |
| Pacira Therapeutics, Inc. | 2 | $27 |
| Johnson & Johnson | 2 | $25 |
| Abbott | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Biogen | 1 | $14 |
| Tersera Therapeutics LLC | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
How this compares
$1,029 in reported general payments places this provider in the 75th percentile of 434 physical medicine & rehabilitation providers in New Jersey.
See all physical medicine & rehabilitation providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PercocetOxycodone Hcl/Acetaminophen | 11 | $49,819 |
| OxycontinOxycodone Hcl | 25 | $15,741 |
| Baclofen | 134 | $3,935 |
| Midodrine Hcl | 15 | $2,529 |
| Gabapentin | 71 | $1,473 |
| Clonidine | 15 | $1,473 |
| Fentanyl | 19 | $1,249 |
| Pregabalin | 44 | $892 |
| Oxycodone Hcl | 39 | $857 |
| Testosterone | 12 | $538 |
| Morphine Sulfate | 14 | $390 |
| Famotidine | 19 | $331 |
| Tramadol Hcl | 20 | $325 |
| Oxybutynin Chloride | 27 | $320 |
| Clonazepam | 31 | $268 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in West Orange
- Yekyung KongWest Orange$61K
- Steven KirshblumWest Orange$47K
- Steven EscaldiEdison$70K
- Joseph IbrahimBayonne$50K
- Joseph ValenzaChester$29K
- Christine GreissEdison$28K
- Bianca MartinezManasquan$25K
- Jason SmithCedar Knolls$19K
- Sandeep RathiLakewood$14K
- Anand PooleriCamden$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.